SkinBioTherapeutics Plc (SBTX.L)
GBp 17.5
(-7.89%)
GBp 17.5
(-7.89%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -2.64 Million | -2.67 Million | -1.55 Million | -892.13 Thousand | -1.42 Million | -667.74 Thousand |
| Net Income | -2.83 Million | -2.79 Million | -1.43 Million | -1.5 Million | -1.14 Million | -844.41 Thousand |
| Depreciation & Amortization | 44.19 Thousand | 29.67 Thousand | 5055.00 | 5100.00 | 3400.00 | - |
| Deferred income taxes | -38.36 Thousand | -1901.00 | -269.69 Thousand | 5947.00 | 68.9 Thousand | - |
| Stock-based compensation | 1273.00 | 52.7 Thousand | 61.25 Thousand | 155.81 Thousand | 77.25 Thousand | 71.85 Thousand |
| Change in working capital | 51.29 Thousand | 110.14 Thousand | -123.32 Thousand | 355.45 Thousand | -146.15 Thousand | 57.76 Thousand |
| Other non-cash items | 131.62 Thousand | -71.05 Thousand | 204.62 Thousand | 85.64 Thousand | -283.94 Thousand | 47.04 Thousand |
| Investing Cash Flow | -165.27 Thousand | -96.81 Thousand | -112.3 Thousand | -73.67 Thousand | -69.39 Thousand | -72.26 Thousand |
| Investments in PPE | -165.27 Thousand | -96.81 Thousand | -112.3 Thousand | -73.66 Thousand | -10.2 Thousand | -72.26 Thousand |
| Acquisitions | - | - | - | -5.00 | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -75.48 Thousand | -96.81 Thousand | -112.3 Thousand | -73.66 Thousand | -59.19 Thousand | -72.26 Thousand |
| Financing Cash Flow | 2.31 Million | -35.12 Thousand | 4.11 Million | - | 1.44 Million | - |
| Debt repayment | -36.1 Thousand | -35.12 Thousand | -2927.00 | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 2.35 Million | - | 4.12 Million | - | 1.44 Million | - |
| Other Financing Activities | 2.31 Million | -35.12 Thousand | 4.11 Million | - | 1.44 Million | - |
| Accounts receivables | -54.73 Thousand | 130.79 Thousand | -198.32 Thousand | 171.95 Thousand | -146.15 Thousand | 57.76 Thousand |
| Accounts payables | 16.95 Thousand | 101.92 Thousand | - | - | - | - |
| Inventory | 89.07 Thousand | -122.57 Thousand | - | - | - | - |
| Other working capital | 16.95 Thousand | - | 74.99 Thousand | 183.49 Thousand | -90.95 Thousand | 90.63 Thousand |
| Cash at beginning of period | 1.8 Million | 4.6 Million | 2.15 Million | 3.12 Million | 3.18 Million | 3.92 Million |
| Cash at end of period | 1.31 Million | 1.8 Million | 4.6 Million | 2.15 Million | 3.12 Million | 3.18 Million |
| Capital Expenditure | -165.27 Thousand | -96.81 Thousand | -112.3 Thousand | -73.66 Thousand | -10.2 Thousand | -72.26 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -493.08 Thousand | -2.8 Million | 2.45 Million | -965.81 Thousand | -58.03 Thousand | -740 Thousand |
| Free Cash Flow | -2.81 Million | -2.76 Million | -1.66 Million | -965.8 Thousand | -1.43 Million | -740 Thousand |
| Breakdown | 2023 Q2 | 2022 FY | 2022 Q4 | 2022 Q2 | 2021 FY | 2021 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -1.33 Million | -2.83 Million | -1.55 Million | -1.28 Million | -2.79 Million | -1.71 Million |
| Depreciation & Amortization | 45.11 Thousand | 44.19 Thousand | 27.84 Thousand | 16.34 Thousand | 29.67 Thousand | 15.09 Thousand |
| Deferred income taxes | - | -38.36 Thousand | -208.98 Thousand | 170.61 Thousand | -1901.00 | 439.66 Thousand |
| Stock-based compensation | - | 1273.00 | -20.88 Thousand | 22.15 Thousand | 52.7 Thousand | 31.4 Thousand |
| Change in working capital | 14.86 Thousand | 51.29 Thousand | -174.17 Thousand | 225.46 Thousand | 110.14 Thousand | 501.25 Thousand |
| Other non-cash items | -90.63 Thousand | 131.62 Thousand | 275.13 Thousand | -143.51 Thousand | -71.05 Thousand | -540.33 Thousand |
| Investing Cash Flow | -76.48 Thousand | -165.27 Thousand | -138.08 Thousand | -27.19 Thousand | -96.81 Thousand | -55.27 Thousand |
| Investments in PPE | -14.95 Thousand | -165.27 Thousand | -138.08 Thousand | -27.19 Thousand | -96.81 Thousand | -55.27 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -61.52 Thousand | -75.48 Thousand | -48.28 Thousand | -27.19 Thousand | -96.81 Thousand | -55.27 Thousand |
| Financing Cash Flow | 2.97 Million | 2.31 Million | 2.33 Million | -17.82 Thousand | -35.12 Thousand | -22.83 Thousand |
| Debt repayment | -20.32 Thousand | -36.1 Thousand | - | -17.82 Thousand | -35.12 Thousand | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 2.99 Million | 2.35 Million | 2.35 Million | - | - | - |
| Other Financing Activities | 2.99 Million | 2.31 Million | 2.33 Million | -17.82 Thousand | -35.12 Thousand | -22.83 Thousand |
| Accounts receivables | 28.31 Thousand | -54.73 Thousand | -61.87 Thousand | 7138.00 | 130.79 Thousand | 53.74 Thousand |
| Accounts payables | -35.39 Thousand | 16.95 Thousand | -167.06 Thousand | 184.01 Thousand | 101.92 Thousand | 158.01 Thousand |
| Inventory | -13.45 Thousand | 89.07 Thousand | 54.76 Thousand | 34.31 Thousand | -122.57 Thousand | 289.49 Thousand |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 1.31 Million | 1.8 Million | 765.97 Thousand | 1.8 Million | 4.6 Million | 3.15 Million |
| Cash at end of period | 2.84 Million | 1.31 Million | 1.31 Million | 765.97 Thousand | 1.8 Million | 1.8 Million |
| Capital Expenditure | -14.95 Thousand | -165.27 Thousand | -138.08 Thousand | -27.19 Thousand | -96.81 Thousand | -55.27 Thousand |
| Effect of forex changes on cash | 1.31 Million | - | -1.31 Million | 1.8 Million | - | -1.8 Million |
| Net cash flow / Change in cash | 1.52 Million | -493.08 Thousand | 545.85 Thousand | -1.03 Million | -2.8 Million | -1.34 Million |
| Free Cash Flow | -1.38 Million | -2.81 Million | -1.78 Million | -1.02 Million | -2.76 Million | -1.32 Million |
KKPNF
NWPG
SRGZ
6038
PLX
CGS